alcohol use and glp 1 Emerging pharmacological targets for disorder GLP-1 Drug Semaglutide Substantially Reduced

Loss of control eating disorder in children age 12 years and younger: proposed research criteria

Therapeutic approaches targeting GLP-1 GLP-1 has been translated into multiple approved clinical therapies

April 2, 2025: Lawsuits Against Eli Lillys Trulicity Increase in March There are now 1,685 active lawsuits pending against Trulicitys maker Novo Nordisk and other GLP-1 manufacturers

These medications decreased: Heart failure hospitalizations by 10-11% according to meta-analyzes including over 60,000 patients 14

Patients using oral contraceptives should consider using a non-oral contraceptive method or a backup method for 4 weeks after initiation and after each dose escalation